Equities

Youcare Pharmaceutical Group Co Ltd

688658:SHH

Youcare Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)17.07
  • Today's Change-0.10 / -0.58%
  • Shares traded1.80m
  • 1 Year change-32.24%
  • Beta1.2071
Data delayed at least 15 minutes, as of May 28 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Youcare Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the development and production of chemical drugs. The Company’s products are mainly cardiovascular and cerebrovascular drugs, digestive system drugs, diabetes drugs and anti-infective drugs, including ginkgo biloba extract injection, gastrodin injection, lansoprazole for injection, and omeprazole enteric-coated capsules , metformin hydrochloride sustained-release tablets, cefuroxime sodium for injection and ceftriaxone sodium for injection, etc. The Company conducts its businesses within the China market and to overseas markets.

  • Revenue in CNY (TTM)4.04bn
  • Net income in CNY168.83m
  • Incorporated2001
  • Employees3.18k
  • Location
    Youcare Pharmaceutical Group Co Ltd6 Hongda Middle RdBeijing Econ&Tech Dlvp AreaBEIJING 100176ChinaCHN
  • Phone+86 1 087925985
  • Fax+86 1 087925985
  • Websitehttps://www.youcareyk.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
JiangSu WuZhong Pharmactcl Devlpm Co Ltd2.33bn-95.04m7.29bn1.05k--4.12--3.13-0.1366-0.13663.232.480.55316.072.292,220,525.00-2.31-2.92-4.78-5.3022.4128.14-4.18-5.771.22-0.32320.5063--10.555.655.58---19.08--
Beijing Foyou Pharma Co Ltd3.32bn507.64m7.32bn3.44k14.362.07--2.201.061.066.957.350.74823.469.58967,165.9011.50--14.81--65.14--15.37--2.99--0.0316--3.07--11.36------
Shandong Lukang Pharmaceutical Co Ltd6.28bn267.79m7.46bn6.48k28.492.03--1.190.2920.2926.884.110.71873.546.45967,865.703.212.215.514.0523.5523.414.473.460.73135.390.468931.799.3413.0478.378.81-16.9523.94
Harbin Pharmaceutical Group Co., Ltd.15.67bn449.71m7.51bn9.85k16.311.53--0.47960.18270.18276.341.951.136.353.461,590,093.003.790.741410.201.8926.3023.873.350.72941.0640.410.3930.0011.937.41-14.882.69-5.38--
Youcare Pharmaceutical Group Co Ltd4.04bn168.83m7.73bn3.18k45.702.11--1.910.37570.37578.978.130.65182.074.091,269,471.002.767.114.1511.6559.5464.144.248.071.42--0.207960.95-7.611.05-44.84-7.1623.40--
Shenzhen Lifotronic Technology Co Ltd1.17bn347.69m8.14bn1.48k23.414.27--6.930.81200.81202.754.460.54092.327.90792,478.6015.9713.8219.6616.3365.7061.0129.5226.103.51--0.100441.5116.5528.7830.6632.27-7.91--
Lushang Freda Pharmaceutical Co Ltd4.20bn233.09m8.23bn3.65k35.332.02--1.960.22930.22934.134.010.44460.88327.751,149,606.003.020.69925.845.1248.4420.236.793.452.67--0.125140.33-64.65-12.29567.4413.3644.4014.87
Data as of May 28 2024. Currency figures normalised to Youcare Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

41.31%Per cent of shares held by top holders
HolderShares% Held
China Merchants Fund Management Co., Ltd.as of 31 Dec 202329.46m14.40%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 202320.58m10.06%
CITIC Securities Co., Ltd. (Invt Port)as of 31 Dec 202316.63m8.13%
Taikang Asset Management Co. Ltd.as of 30 Sep 20225.67m2.77%
Essence Fund Co., Ltd.as of 31 Dec 20234.03m1.97%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 20233.55m1.74%
E Fund Management Co., Ltd.as of 31 Dec 20231.34m0.65%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 20231.22m0.60%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 20231.04m0.51%
Hotland Innovation Asset Management Co. Ltd.as of 31 Dec 20231.01m0.49%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.